Bausch Health Companies Inc.

October marks 𝗗𝗲𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗠𝗼𝗻𝘁𝗵—a time to recognize the millions of people impacted by depression each year. Through continued support of the mental health community, Bausch Health maintains ongoing efforts to raise awareness, improve education, and provide appropriate treatment options for healthcare professionals and their patients. Let’s keep #MentalHealth top of mind. #DepressionAwarenessMonth #BauschHealth 

We’re proud to share that the article “Current Trends and Future Directions of the Dual 1550-nm Erbium Glass Fiber and 1927-nm Thulium Fiber Non-Ablative Fractional Laser System” was recognized as Editor’s Choice in Lasers in Surgery and Medicine. This publication provides an overview of current trends and future directions in dual-wavelength non-ablative fractional laser technology, highlighting ongoing scientific research in the field. Congratulations to the authors: Dr. Paul M. Friedman, MD (Dermatology & Laser Surgery Center, Houston, TX), Dr. Jeffrey Dover (SkinCare Physicians, Chestnut Hill, MA), Dr. Anne Chapas (UnionDerm, New York, NY), and Abby Jacobson, PhD, MS, PA-C (Bausch Health Companies Inc., Bridgewater, NJ), on this recognition of their contribution to the scientific dialogue in dermatology and aesthetic medicine. For healthcare professionals only. #SkinResurfacing #Dermatology

Bausch Health has been awarded the “Friend of Polish Cardiology” for the 4th year in a row at the Congress of the Polish Cardiac Society. This award reflects our ongoing commitment to #hearthealth in Poland through education, awareness, and partnerships that improve cardiovascular care. #BauschHealth

It’s Liver Awareness Month! Let’s raise our voices, share resources, and support those impacted. Understanding chronic liver diseases and complications that may arise like hepatic encephalopathy are key to timely intervention and management. Visit https://lnkd.in/eXeV48NP #LiverAwarenessMonth

We’re proud that our nonsurgical devices, Clear + Brilliant® Touch, Fraxel FTX™, and Thermage® FLX, were featured on The Balancing Act, a Lifetime daily morning show hosted by Montel Williams and Olga Villaverde. With an impressive reach of up to 30 million people, this show has been educating its audience for over 20 years on a wide range of topics, including health and wellness, family, and beauty trends, to empower viewers to enhance many aspects of their lives. In this special episode, medical aesthetician Amy Peterson, LFA, LME, and board-certified dermatologist Dr. Aaron Chen performed a Fraxel FTX™ treatment and were interviewed by co-host Montel Williams about its role in skin rejuvenation. Co-host Olga Villaverde also sat down with board-certified dermatologist Dr. Shino Bay Aguilera and medical aesthetician Melinda Leyva, LFA, LME, to experience Clear + Brilliant® Touch and Thermage® FLX treatments firsthand. For the in-studio filming, Harvard fellowship-trained dermatologist Dr. Michael Abrouk joined the program to share insights on all three of these trusted nonsurgical devices. The episode will air on October 2 and 24, 2025, at 7:30 a.m. ET and PT. Read our press release about this exciting activation here: https://lnkd.in/ePYN_5g2. Solta is sponsoring this program. Bausch Health Companies Inc. Individual results may vary. Ask your doctor if Clear + Brilliant, Fraxel, and/or Thermage is right for you. Visit solta.com for Important Safety Information and product details.

𝟭 𝗶𝗻 𝟯 people will die prematurely from cardiovascular disease (CVD). The good news? Up to 𝟴𝟬% of heart disease and stroke cases are 𝗽𝗿𝗲𝘃𝗲𝗻𝘁𝗮𝗯𝗹𝗲. That’s why we support patients and healthcare providers across regions — including throughout the EMEA, Canada, and Mexico — with access to therapies that can help improve cardiovascular and cardiometabolic outcomes. Prevention, early detection, and consistent care can change the trajectory of someone’s life. 💙 #HeartHealthDay2025 #BauschHealth  

Ahead of #HeartHealthDay, we’re proud to support expanded access to 𝗰𝗮𝗿𝗱𝗶𝗼𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝗰 𝗵𝗲𝗮𝗹𝘁𝗵 𝗰𝗮𝗿𝗲 in Mexico through Bausch Health’s Laboratorios Grossman. Cardiometabolic conditions are among the most pressing health challenges globally, and a growing concern across Latin America. Metabolic risk factors — including high blood pressure, elevated glucose levels, and obesity — are the leading contributors to cardiovascular diseases (CVDs). We’re bringing innovative solutions that support healthier hearts and healthier lives. #GrossmanCardiometabolic #BauschHealth 

𝗛𝗮𝗽𝗽𝘆 𝗜𝗧 𝗣𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀 𝗗𝗮𝘆! Did you know IT is behind so much of what keeps our business running smoothly? Here are just a few ways IT makes an impact every day at Bausch Health: 1️⃣ 𝗞𝗲𝗲𝗽𝘀 𝘂𝘀 𝗰𝗼𝗻𝗻𝗲𝗰𝘁𝗲𝗱. Our Network Team ensures speed, security, and resilience—even during outages. 2️⃣ 𝗣𝗿𝗼𝘁𝗲𝗰𝘁𝘀 𝗼𝘂𝗿 𝗱𝗮𝘁𝗮 𝟮𝟰/𝟳. Our Security Operations team monitors and responds to threats around the clock, partnering globally to keep our systems safe. 3️⃣ 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗲𝘀 𝘁𝗼 𝘀𝘁𝗮𝘆 𝗮𝗵𝗲𝗮𝗱 𝗼𝗳 𝗰𝘆𝗯𝗲𝗿 𝗿𝗶𝘀𝗸𝘀. Our Information Security Architecture team builds custom solutions to safeguard our business. 4️⃣ 𝗦𝘂𝗽𝗽𝗼𝗿𝘁𝘀 𝗰𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 𝗮𝗻𝗱 𝗿𝗲𝗮𝗱𝗶𝗻𝗲𝘀𝘀. Our Governance, Risk, and Compliance teams manage IT policies, audits, and disaster recovery planning to keep us prepared. 5️⃣𝗦𝘁𝗿𝗲𝗮𝗺𝗹𝗶𝗻𝗲𝘀 𝗴𝗹𝗼𝗯𝗮𝗹 𝗼𝗽𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀. Our IT teams streamline regulatory submissions worldwide through global system expansion. Thank you to our IT colleagues for your dedication, innovation, and tireless support! #ITProfessionalsDay #BauschHealth

We are pleased to announce that Bausch Health has completed its acquisition of DURECT Corporation. This milestone brings an investigational, novel epigenetic modulator with FDA Breakthrough Therapy Designation into our #hepatology pipeline, with the potential to become the first FDA-approved treatment for alcohol-associated hepatitis. Read the full press release here: https://lnkd.in/efY8mefg #DURECT #BauschHealth